BB&T Securities’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $2.95M | Sell |
12,677
-1,916
| -13% | -$446K | 0.03% | 485 |
|
|
2019
Q2 | $3.41M | Sell |
14,593
-1,667
| -10% | -$390K | 0.03% | 457 |
|
|
2019
Q1 | $3.84M | Buy |
16,260
+3,381
| +26% | +$799K | 0.04% | 429 |
|
|
2018
Q4 | $3.88M | Sell |
12,879
-316
| -2% | -$95.1K | 0.04% | 405 |
|
|
2018
Q3 | $4.66M | Sell |
13,195
-1,233
| -9% | -$436K | 0.05% | 409 |
|
|
2018
Q2 | $4.19M | Buy |
14,428
+1,254
| +10% | +$364K | 0.04% | 416 |
|
|
2018
Q1 | $3.61M | Sell |
13,174
-678
| -5% | -$186K | 0.04% | 444 |
|
|
2017
Q4 | $4.41M | Buy |
13,852
+65
| +0.5% | +$20.7K | 0.06% | 357 |
|
|
2017
Q3 | $4.32M | Buy |
13,787
+798
| +6% | +$250K | 0.06% | 361 |
|
|
2017
Q2 | $3.52M | Buy |
12,989
+2,598
| +25% | +$705K | 0.05% | 387 |
|
|
2017
Q1 | $2.84M | Buy |
10,391
+1,702
| +20% | +$465K | 0.04% | 394 |
|
|
2016
Q4 | $2.72M | Hold |
8,689
| – | – | 0.04% | 368 |
|
|
2016
Q3 | $2.72M | Sell |
8,689
-2,775
| -24% | -$868K | 0.04% | 368 |
|
|
2016
Q2 | $2.77M | Sell |
11,464
-169
| -1% | -$40.9K | 0.04% | 363 |
|
|
2016
Q1 | $3.03M | Buy |
11,633
+289
| +3% | +$75.2K | 0.05% | 323 |
|
|
2015
Q4 | $3.48M | Buy |
11,344
+5,103
| +82% | +$1.56M | 0.07% | 250 |
|
|
2015
Q3 | $1.82M | Buy |
6,241
+1,766
| +39% | +$515K | 0.04% | 363 |
|
|
2015
Q2 | $1.81M | Buy |
4,475
+150
| +3% | +$60.6K | 0.04% | 370 |
|
|
2015
Q1 | $18.3M | Buy |
4,325
+929
| +27% | +$3.92M | 0.04% | 360 |
|
|
2014
Q4 | $11.5M | Buy |
3,396
+887
| +35% | +$3.01M | 0.03% | 467 |
|
|
2014
Q3 | $8.3M | Buy |
2,509
+289
| +13% | +$956K | 0.02% | 520 |
|
|
2014
Q2 | $7M | Buy |
2,220
+605
| +37% | +$1.91M | 0.02% | 566 |
|
|
2014
Q1 | $4.94M | Buy |
1,615
+196
| +14% | +$599K | 0.01% | 598 |
|
|
2013
Q4 | $3.97M | Buy |
1,419
+229
| +19% | +$640K | 0.01% | 632 |
|
|
2013
Q3 | $2.87M | Buy |
1,190
+195
| +20% | +$469K | 0.01% | 667 |
|
|
2013
Q2 | $2.14K | Buy |
+995
| New | +$2.14K | 0.01% | 717 |
|